Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q4 2017 call → NOWe need to determine if management explains the company's business going forward by narrating what its counterparties are doing and scaling. The question asks: does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, etc., that the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' trajectories? We need to look at the transcript. The company is TPG Specialty Lending, a BDC. They make loans to companies. The "counterparties" would be the borrowers. Management discusses their portfolio, originations, repayments, etc. They talk about specific investments like iHeart, Northern Oil, etc. But do they narrate the growth or expansion of those borrowers as the driver of their own future business? The company's business is lending; their forward account is about deploying capital, sourcing deals, managing portfolio. They talk about market conditions, competition, their own underwriting discipline, etc. They mention specific deals but not in terms of the borrowers' own ramps or expansions driving TSLX's volume. They talk about iHeart restructuring, but that's about repayment, not growth. They talk about Northern Oil as a large facility they underwrote, but not about the borrower's expansion plans. They discuss their own origination pipeline, but not specific counterparties' trajectories. They mention TCAP investment, but that's an equity stake in another BDC, not a customer. They talk about tax reform impact on borrowers, but that's macro. They don't describe a scenario where a specific borrower is scaling up and that will drive TSLX's lending volume. The forward outlook is about their own sourcing, market volatility, etc. So the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.